- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/26 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 237/26
Total number of patents in this class: 155
10-year publication summary
|
7
|
16
|
7
|
6
|
10
|
10
|
11
|
12
|
9
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Tagworks Pharmaceuticals B.V. | 56 |
9 |
| Hallura Ltd. | 13 |
6 |
| Merck Patent GmbH | 5669 |
5 |
| Rigel Pharmaceuticals, Inc. | 509 |
5 |
| President and Fellows of Harvard College | 6060 |
4 |
| Transthera Sciences (nanjing), Inc. | 79 |
4 |
| The Regents of the University of California | 20590 |
3 |
| Boehringer Ingelheim Vetmedica GmbH | 1273 |
3 |
| Centre National de La Recherche Scientifique | 10914 |
3 |
| Mirati Therapeutics, Inc. | 285 |
3 |
| Vanderbilt University | 1991 |
3 |
| F. Hoffmann-La Roche AG | 7847 |
2 |
| LG Chem, Ltd. | 17883 |
2 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| Bayer AG | 3470 |
2 |
| Monsanto Technology LLC | 8199 |
2 |
| Abbvie Inc. | 1837 |
2 |
| Northwestern University | 3530 |
2 |
| Gilead Sciences, Inc. | 2207 |
2 |
| Illumina, Inc. | 3483 |
2 |
| Other owners | 89 |